Blue Bird Corporation (BLBD) is poised to release its latest quarterly results after Wednesday's market close. Investors will be watching to see if the manufacturer can maintain its pattern of outperforming Wall Street's forecasts amidst a mixed landscape for heavy equipment peers.
CME Group is set to report fourth-quarter earnings Wednesday morning, with analysts forecasting a 7.8% revenue increase. The derivatives exchange operator's performance may signal broader capital markets health as peers post mixed results.
The global electronics manufacturer is poised to release its quarterly results Wednesday, with investors watching for signs of stabilization after a period of revenue contraction.
Tenable Holdings, a leader in exposure management, reports its fourth-quarter earnings after the bell Wednesday. All eyes will be on whether the company can maintain its track record of revenue beats against a backdrop of slowing growth forecasts and a battered cybersecurity sector.
Payment technology firm WEX Inc. is set to release its quarterly financial results after Wednesday's market close, with Wall Street anticipating a return to revenue growth following last year's dip.
Silgan Holdings is set to report fourth-quarter earnings Wednesday morning, with Wall Street eyeing slowing revenue growth and the company's ability to outperform in a mixed industrial packaging landscape.
Compass Point Research suggests the prolonged cryptocurrency downturn may be nearing its end, with Bitcoin finding a potential bottom around $60,000-$68,000 unless broader market turmoil intervenes.
The Hennepin County Medical Examiner has ruled the death of Alex Pretti, a 37-year-old nurse shot by federal agents during a Minneapolis immigration protest, a homicide by multiple gunshot wounds, as witness accounts and footage challenge the official narrative of the incident.
Vera Therapeutics appoints industry veteran Matt Skelton as Chief Commercial Officer, signaling a strategic pivot toward commercialization as its lead drug candidate for IgA nephropathy, atacicept, undergoes FDA Priority Review.
Kemper Corporation is set to report its fourth-quarter earnings Wednesday afternoon, with investors watching closely for signs of stability after a period of mixed performance and sector-wide pressure.
As Kulicke & Soffa prepares to release its fourth-quarter results, investors are watching to see if the semiconductor equipment specialist can meet elevated expectations amid a sector-wide rebound.
The pharmaceutical giant is set to release quarterly results before the bell Wednesday, with Wall Street anticipating another period of blockbuster revenue growth driven by its GLP-1 drugs.
All eyes are on Qualcomm as it prepares to release its quarterly earnings. With a strong track record of surpassing estimates, analysts are watching for signs of resilience in the smartphone and IoT markets.
Matrix Service Company (MTRX) is set to release its fourth-quarter financial results after the market closes Wednesday. Investors will be watching to see if the industrial construction firm can meet elevated revenue forecasts and translate top-line growth into stronger profitability.
The global insurer faces heightened scrutiny after a recent revenue miss, with analysts projecting a sharp year-over-year sales increase as peers post mixed results.
All eyes are on Corpay (NYSE: CPAY) as the business payments firm prepares to release its quarterly results after Wednesday's closing bell. Analysts project robust revenue growth, but a history of misses adds intrigue to the report.
As Mueller Water Products prepares to release its fourth-quarter results, investors are watching for signs of sustained growth in the critical water infrastructure sector. The company has a strong track record of exceeding revenue expectations.
As Everest Group prepares to report its fourth-quarter results, investors are weighing a history of revenue misses against a stabilizing analyst outlook and a mixed performance across the insurance sector.
GE HealthCare Technologies prepares to release its fourth-quarter financial results amid steady analyst expectations and a mixed performance landscape for medical equipment peers.
As T. Rowe Price Group prepares to release its fourth-quarter results, investors are weighing steady revenue growth expectations against a history of occasional misses and a mixed landscape for custody banks.
